Scarica l'app Stockscreener
7.25
0.97%
0.07
Dopo l'orario di chiusura:
7.25
Precedente Chiudi:
$7.18
Aprire:
$7.02
Volume 24 ore:
44,031
Relative Volume:
0.29
Capitalizzazione di mercato:
$81.11M
Reddito:
$3.57M
Utile/perdita netta:
$-7.80M
Rapporto P/E:
-7.4719
EPS:
-0.9703
Flusso di cassa netto:
$-6.56M
1 W Prestazione:
+3.57%
1M Prestazione:
+15.08%
6M Prestazione:
+127.27%
1 anno Prestazione:
+237.21%
Intervallo 1D:
$6.75
$7.35
Intervallo di 1 settimana:
$6.44
$7.62
Portata 52W:
$1.33
$7.97
Neuraxis Inc Stock (NRXS) Company Profile
Nome
Neuraxis Inc
Settore
Industria
Telefono
(812) 689-0791
Indirizzo
11550 North Meridian Street, Suite 325, Carmel
Compare NRXS vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
7.25 | 81.11M | 3.57M | -7.80M | -6.56M | -0.9703 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Neuraxis Inc Borsa (NRXS) Ultime notizie
NRXS PE Ratio & Valuation, Is NRXS Overvalued - Intellectia AI
Top NeurAxis Insiders Make Bold Moves With Fresh Stock Buys - TipRanks
Neuraxis CEO Carrico buys $15,797 in company stock By Investing.com - Investing.com Australia
Neuraxis CFO Henrichs buys $14,882 in company stock - Investing.com
Neuraxis Inc: CRO Carrico buys $1307 in shares By Investing.com - Investing.com India
Neuraxis CFO Henrichs buys $14,882 in company stock By Investing.com - Investing.com South Africa
Insider Buying: NeurAxis (NASDAQ:NRXS) CFO Buys 7,593 Shares of Stock - MarketBeat
Insider Buying: NeurAxis (NASDAQ:NRXS) CEO Buys 8,060 Shares of Stock - MarketBeat
Neuraxis CEO Carrico buys $15,797 in company stock - Investing.com
Neuraxis Inc: CRO Carrico buys $1307 in shares - Investing.com
Neuraxis (NRXS) CFO acquires 7,593 shares at $1.96 in open trade - Stock Titan
Neuraxis (NRXS) executive makes small open-market share purchase - Stock Titan
Neuraxis (NRXS) CEO boosts stake with open-market buy of 8,060 shares - Stock Titan
Aug Final Week: Is NeurAxis Inc a speculative investmentVolume Spike & Real-Time Stock Movement Alerts - baoquankhu1.vn
New Highs: Can NeurAxis Inc expand its profit marginsQuarterly Investment Review & Real-Time Stock Entry Alerts - baoquankhu1.vn
Insider Trends: Does NeurAxis Inc have pricing power2026 Levels & Technical Confirmation Alerts - baoquankhu1.vn
Treasury Yields: Should I trade or invest in NeurAxis Inc2026 Pullbacks & Capital Efficiency Focused Ideas - baoquankhu1.vn
NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth - TradingView
NeurAxis Shares Rise After Q4 Results Driven by Robust Revenue Expansion - Bitget
If You Invested $1,000 in Neuraxis Inc (NRXS) - Stock Titan
Craig Hallum Increases NeurAxis (NASDAQ:NRXS) Price Target to $13.00 - Defense World
Dip Buying: Can NeurAxis Inc outperform under higher oil prices2026 Trading Recap & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Gainers Report: Can NeurAxis Inc expand its profit marginsEarnings Beat & AI Powered Market Entry Ideas - baoquankhu1.vn
Neuraxis, Inc.: Fundamental Analysis and Financial Ratings | NRXS | US64134X2018 - marketscreener.com
NeurAxis (NASDAQ:NRXS) Given New $13.00 Price Target at Craig Hallum - MarketBeat
NeurAxis revenue up 27% year to USD 968000 in Q4FY25 - Medical Buyer
NeurAxis Earnings Call: Reimbursement Wins Drive Next Phase - TipRanks
Earnings call transcript: NeurAxis Q4 2025 sees revenue growth, stock dips - Investing.com Australia
NeurAxis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
NeurAxis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
NRXS: FY2025 revenue rose 33% to $3.6M, with improved net loss and expanded market access - tradingview.com
NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph
Neuraxis 10-K: $3.57M Revenue, $(7.80)M Net Loss - TradingView
Neuraxis (NRXS) expands IB-Stim GI neuromodulation, RED constipation device and IP moat - Stock Titan
Levels Update: Should I trade or invest in NeurAxis Inc2026 Top Gainers & Expert Curated Trade Ideas - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Argenx Se (ARGX) and Teladoc (TDOC) - The Globe and Mail
Aug Ideas: What is the implied volatility of NeurAxis Inc2026 Fed Impact & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
NeurAxis, Inc. Auditor Raises 'Going Concern' Doubt - MarketScreener
NeurAxis, Inc. Hits New 52-Week High of $7.46, Up 141.44% - Markets Mojo
Breakout Zone: Is NeurAxis Inc impacted by rising ratesTrade Exit Report & Stock Portfolio Risk Control - baoquankhu1.vn
NeurAxis, Inc. Hits New 52-Week High at USD 7.34 - Markets Mojo
Neuraxis price target raised to $8 from $7 at Craig-Hallum - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026 - Sahm
Medical tech firm NeurAxis schedules March 19 call on 2025 results - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
NeurAxis (NASDAQ:NRXS) Shares Up 0.7%Still a Buy? - MarketBeat
NeurAxis, Inc. Hits New 52-Week High of $6.35, Up 98.97% - Markets Mojo
Volume Recap: Can TTWO expand its profit marginsJuly 2025 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
How FlexShares iBoxx 3 Year Target stock trades in high volatilityMarket Activity Summary & Reliable Price Breakout Signals - Naître et grandir
Update Recap: Should you avoid OSCR stock right now2025 Macro Impact & Entry Point Confirmation Alerts - baoquankhu1.vn
Neuraxis Inc Azioni (NRXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Capitalizzazione:
|
Volume (24 ore):